Boston Scientific Corporation (BIT:1BSX)

Italy · Delayed Price · Currency is EUR

62.40

-0.60 (-0.95%)

At close: Feb 11, 2026

-38.82% (1Y)

Market Cap	92.53B -35.5%
Revenue (ttm)	17.10B +19.9%
Net Income	2.47B +56.3%
EPS	1.65 +55.2%
Shares Out	n/a
PE Ratio	37.49
Forward PE	21.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	148
Average Volume	339
Open	62.20
Previous Close	63.00
Day's Range	61.80 - 62.20
52-Week Range	61.80 - 103.00
Beta	n/a
RSI	20.65
Earnings Date	Feb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1979

Employees 53,000

Stock Exchange Borsa Italiana

Ticker Symbol 1BSX

Full Company Profile

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD Financial Statements